Schimmel Paul
Director at ATYR; Director at ALNY; Director at Sirtris Pharmaceuticals, Inc., and 1 more
- Sold, on record
- $16.7M
- Dollars the filings state
- Form 4 sales
- 15
- Latest May 20, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 4
- Filed as an executive or holder
Companies
- ATYRaTYR PHARMA INCDirector
- ALNYALNYLAM PHARMACEUTICALS, INC.Director
- Sirtris Pharmaceuticals, Inc.Director
- ALKERMES INCDirector
Sales by reason
0
Routine
8
Plan not stated
0
No plan
7
Unusual
Form 4 sales per year, every sale on record.
Sales by company
- ALNY253,823 shares
- Sirtris Pharmaceuticals, Inc.11,503 shares
- ATYR8,447 shares
- ALKERMES INC5,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- May 20, 2020Plan not stated
Sold 1.9% of their holdings
$31k8,447 shares at $3.64
- Mar 13, 2018Unusual
Sold 100% of their holdings
$4.2M27,823 shares at $150.00
- Apr 21, 2015Unusual
Sold 100% of their holdings
$1.3M10,000 shares at $130.02
- Mar 19, 2015Unusual
Sold 100% of their holdings
$1.2M10,000 shares at $120.00
- Dec 8, 2014Unusual
Sold 100% of their holdings
$1.6M15,000 shares at $105.00
- Oct 28, 2014Unusual
Sold 100% of their holdings
$1.4M15,000 shares at $95.00
- Jan 13, 2014Unusual
Sold 100% of their holdings
$1.3M15,000 shares at $85.36
- Dec 20, 2013Unusual
Sold 100% of their holdings
$975k15,000 shares at $65.00
- Oct 22, 2013Plan not stated
Sold 10.6% of their holdings
$900k15,000 shares at $60.00
- Sep 10, 2009Plan not stated
Sold 22.3% of their holdings
$1M45,600 shares at $22.15
10 of 15
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| May 27, 2026 | May 28, 2026 | ATYR | Director | Bought | 100,000 | $0.50 | $50k | 779,143 | SEC |
| May 11, 2026 | May 13, 2026 | ATYR | Director | AwardedStock Option (right to buy) | 50,000 | 50,000 | SEC | ||
| Oct 9, 2025 | Oct 9, 2025 | ATYR | Director | Bought | 1M | $0.91 | $913k | 1.4M | SEC |
| May 1, 2025 | May 2, 2025 | ATYR | Director | AwardedStock Option (right to buy) | 50,000 | 50,000 | SEC | ||
| Jul 24, 2024 | Jul 24, 2024 | ATYR | Director | Bought | 100,000 | $1.84 | $184k | 413,023 | SEC |
| May 22, 2024 | May 23, 2024 | ATYR | Director | AwardedStock Option (right to buy) | 24,000 | 24,000 | SEC | ||
| May 17, 2023 | May 19, 2023 | ATYR | Director | AwardedStock Option (right to buy) | 12,000 | 12,000 | SEC | ||
| May 10, 2023 | May 11, 2023 | ATYR | Director | Bought | 200,000 | $2.25 | $450k | 313,023 | SEC |
| Apr 26, 2023 | Apr 28, 2023 | ATYR | Director | Exercised or settledRestricted Stock Unit | 6,000 | 0 | SEC | ||
| Apr 26, 2023 | Apr 28, 2023 | ATYR | Director | Exercised options | 6,000 | 8,890 | SEC | ||
| Apr 26, 2022 | Apr 28, 2022 | ATYR | Director | AwardedRestricted Stock Units | 6,000 | 6,000 | SEC | ||
| Sep 20, 2021 | Sep 22, 2021 | ATYR | Director | Bought | 250,000 | $8.00 | $2M | 252,890 | SEC |
| Sep 20, 2021 | Sep 22, 2021 | ATYR | Director | Gift | 500,000 | 679,143 | SEC | ||
| May 18, 2021 | May 20, 2021 | ATYR | Director | Bought | 50,000 | $3.98 | $199k | 113,023 | SEC |
| Apr 28, 2021 | Apr 29, 2021 | ATYR | Director | AwardedStock Option (right to buy) | 1,428 | 1,428 | SEC | ||
| May 20, 2020 | May 22, 2020 | ATYR | Director | Sold | 8,447 | $3.64 | $31k | 429,143 | SEC |
| May 6, 2020 | May 8, 2020 | ATYR | Director | AwardedStock Option (right to buy) | 1,428 | 1,428 | SEC | ||
| Feb 10, 2020 | Feb 11, 2020 | ATYR | Director | Bought | 254,000 | $4.25 | $1.1M | 437,590 | SEC |
| Oct 4, 2019 | Oct 4, 2019 | FBRX | Director | AwardedStock Option (right to buy) | 7,500 | 7,500 | SEC | ||
| Jul 1, 2019 | Jul 2, 2019 | ALNY | Director | AwardedStock Option (right to buy) | 9,000 | 9,000 | SEC | ||
| May 29, 2019 | May 31, 2019 | FBRX | Director | AwardedStock option (right to buy) | 20,000 | 20,000 | SEC | ||
| May 8, 2019 | May 10, 2019 | ATYR | Director | AwardedStock Option (right to buy) | 20,000 | 20,000 | SEC | ||
| Apr 12, 2019 | Apr 16, 2019 | ATYR | Director | Awarded | 1.8M | $0.54 | $998k | 2.6M | SEC |
| Nov 26, 2018 | Nov 28, 2018 | ATYR | Director | Bought | 147,225 | $0.54 | $80k | 882,302 | SEC |
| Sep 4, 2018 | Sep 5, 2018 | ATYR | Director | Bought | 42,749 | $0.74 | $32k | 735,077 | SEC |
| Aug 30, 2018 | Aug 31, 2018 | ATYR | Director | Bought | 164,411 | $0.74 | $122k | 692,328 | SEC |
| Jun 21, 2018 | Jun 25, 2018 | FBRX | Director | AwardedStock option (right to buy) | 20,000 | 20,000 | SEC | ||
| Jun 20, 2018 | Jun 22, 2018 | ALNY | Director | AwardedStock Option (right to buy) | 9,000 | 9,000 | SEC | ||
| May 18, 2018 | May 21, 2018 | ATYR | Director | Bought | 150,000 | $1.00 | $150k | 527,917 | SEC |
| May 15, 2018 | May 17, 2018 | ATYR | Director | AwardedStock Option (right to buy) | 20,000 | 20,000 | SEC | ||
| Mar 13, 2018 | Mar 14, 2018 | ALNY | Director | Sold | 27,823 | $150.00 | $4.2M | 0 | SEC |
| Mar 13, 2018 | Mar 14, 2018 | ALNY | Director | Exercised or settledStock Option (right to buy) | 27,823 | 0 | SEC | ||
| Mar 13, 2018 | Mar 14, 2018 | ALNY | Director | Exercised options | 27,823 | $49.24 | $1.4M | 27,823 | SEC |
| Aug 31, 2017 | Sep 5, 2017 | ATYR | Director | BoughtWarrant to Purchase Common Stock | 35,376 | 35,376 | SEC | ||
| Aug 31, 2017 | Sep 5, 2017 | ATYR | Director | Bought | 94,336 | $2.65 | $250k | 377,917 | SEC |
| Jun 2, 2017 | Jun 6, 2017 | ALNY | Director | AwardedStock Option (right to buy) | 11,250 | 11,250 | SEC | ||
| May 9, 2017 | May 11, 2017 | ATYR | Director | AwardedStock Option (right to buy) | 20,000 | 20,000 | SEC | ||
| Apr 19, 2017 | Apr 21, 2017 | FBRX | Director | Bought | 10,000 | $10.00 | $100k | 13,623 | SEC |
| Apr 19, 2017 | Apr 21, 2017 | FBRX | Director | ConvertedSeries H Preferred Stock | 240,316 | 0 | SEC | ||
| Apr 19, 2017 | Apr 21, 2017 | FBRX | Director | Converted | 34,827 | 3,623 | SEC | ||
| Apr 12, 2017 | Apr 12, 2017 | FBRX | Director | AwardedStock Option (right to buy) | 4,528 | 4,528 | SEC | ||
| Dec 21, 2016 | Dec 22, 2016 | ATYR | Director | Bought | 25,000 | $2.27 | $57k | 721,814 | SEC |
| Dec 16, 2016 | Dec 19, 2016 | ATYR | Director | Bought | 50,000 | $2.48 | $124k | 696,814 | SEC |
| Sep 23, 2016 | Dec 19, 2016 | ATYR | Director | Gift | 25,144 | 646,814 | SEC | ||
| Jun 3, 2016 | Jun 7, 2016 | ALNY | Director | AwardedStock Option (right to buy) | 11,250 | 11,250 | SEC | ||
| May 24, 2016 | May 26, 2016 | ATYR | Director | AwardedStock Option (right to buy) | 18,000 | 18,000 | SEC | ||
| Apr 14, 2016 | Apr 15, 2016 | ATYR | Director | Bought | 66,219 | $4.18 | $277k | 53,012 | SEC |
| Apr 13, 2016 | Apr 14, 2016 | ATYR | Director | Bought | 9,835 | $3.85 | $38k | 249,962 | SEC |
| Apr 12, 2016 | Apr 13, 2016 | ATYR | Director | Bought | 9,127 | $3.71 | $34k | 240,127 | SEC |
| Apr 11, 2016 | Apr 12, 2016 | ATYR | Director | Bought | 32,659 | $3.57 | $117k | 220,231 | SEC |
Page 1
Sales and notices (15)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 20, 2020 | May 22, 2020 | ATYR | Director | Form 4 sale | 8,447 | $31k | 1.9% | Plan not stated | SEC |
| Mar 13, 2018 | Mar 14, 2018 | ALNY | Director | Form 4 sale | 27,823 | $4.2M | 100.0% | Unusual | SEC |
| Apr 21, 2015 | Apr 23, 2015 | ALNY | Director | Form 4 sale | 10,000 | $1.3M | 100.0% | Unusual | SEC |
| Mar 19, 2015 | Mar 19, 2015 | ALNY | Director | Form 4 sale | 10,000 | $1.2M | 100.0% | Unusual | SEC |
| Dec 8, 2014 | Dec 10, 2014 | ALNY | Director | Form 4 sale | 15,000 | $1.6M | 100.0% | Unusual | SEC |
| Oct 28, 2014 | Oct 30, 2014 | ALNY | Director | Form 4 sale | 15,000 | $1.4M | 100.0% | Unusual | SEC |
| Jan 13, 2014 | Jan 14, 2014 | ALNY | Director | Form 4 sale | 15,000 | $1.3M | 100.0% | Unusual | SEC |
| Dec 20, 2013 | Dec 23, 2013 | ALNY | Director | Form 4 sale | 15,000 | $975k | 100.0% | Unusual | SEC |
| Oct 22, 2013 | Oct 24, 2013 | ALNY | Director | Form 4 sale | 15,000 | $900k | 10.6% | Plan not stated | SEC |
| Sep 10, 2009 | Sep 11, 2009 | ALNY | Director | Form 4 sale | 45,600 | $1M | 22.3% | Plan not stated | SEC |
| Sep 4, 2009 | Sep 9, 2009 | ALNY | Director | Form 4 sale | 29,400 | $647k | 12.6% | Plan not stated | SEC |
| Dec 4, 2007 | Dec 4, 2007 | ALNY | Director | Form 4 sale | 7,192 | $229k | 10.3% | Plan not stated | SEC |
| Dec 3, 2007 | Dec 4, 2007 | ALNY | Director | Form 4 sale | 48,808 | $1.6M | 17.0% | Plan not stated | SEC |
| Nov 30, 2007 | Dec 4, 2007 | Sirtris Pharmaceuticals, Inc. | Director | Form 4 sale | 11,503 | $196k | 3.3% | Plan not stated | SEC |
| Mar 2, 2006 | Mar 3, 2006 | ALKERMES INC | Director | Form 4 sale | 5,000 | $130k | 1.4% | Plan not stated | SEC |